ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2018 American Transplant Congress

    Evaluation of a Marine OXYgen Carrier (Hemo2Life®) for Organ Preservation: First Use in Kidney Transplantation in Humans

    Y. Le Meur,1 E. Morellon,2 M. Essig,3 A. Thierry,4 M. Buchler,5 S. Drouin,6 C. Deruelle,1 L. Badet,2 F. Pesteil,3 P-.O. Delpech,4 J-.M. Boutin,5 B. Barrou.6

    1Transplantation, University Hospital, Brest, France; 2Hopital Edouard Herriot, Lyon, France; 3University Hospital, Limoges, France; 4University Hospital, Poitiers, France; 5University Hospital, Tours, France; 6La Pitié Salpetrière, Paris, France.

    Preventing ischemia/reperfusion injuries (IRIs) is a major issue in organ transplantation. At present, grafts are preserved at 4[deg]C in preservation solution in order to reduce…
  • 2018 American Transplant Congress

    Does DGF Result in Worse Outcomes in a Second Transplant?

    B. Muth,1 B. Astor,1,2 J. Blazel,1 J. Turk,1 D. Mandelbrot,1 A. Djamali,1 S. Parajuli.1

    1Department of Medicine, University of Wisconsin, Madison, WI; 2Department of Population Health, University of Wisconsin, Madison, WI.

    Delayed graft function (DGF) is a risk factor for patient death, kidney allograft loss, reduced allograft function and acute rejection after kidney transplantation. Prior transplant…
  • 2018 American Transplant Congress

    Pilot Study of Health IT Feasibility and Impact on Quality of Life for Young Adult Kidney Transplant Recipients

    C. Blosser, R. Katz, J. Himmelfarb, N. Bansal.

    Nephrology, University of Washington, Seattle, WA.

    Background: Young adult kidney transplant recipients (KTRs) are an at-risk population and long-term survival rates are significantly lower than expected. A large majority of young…
  • 2018 American Transplant Congress

    Furosemide Stress Test as a Predicting Biomarker for Delayed Graft Function in Kidney Transplantation

    S. Udomkarnjananun,1 N. Townamchai,1 K. Iampenkhae,2 Y. Avihingsanon,1 S. Eiam-Ong,1 K. Praditpornsilpa.1

    1Nephrology, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; 2Pathology, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

    Delayed graft function (DGF) is considered as a risk factor for long-term allograft failure and rejection episodes.There is currently no biomarker in the immediate post-kidney…
  • 2018 American Transplant Congress

    Treatment of HCV Infection in Renal Transplant Recipients

    M. Rial, L. Tana, C. Alonso, H. Curcio, E. Chulluyan, D. Casadei.

    Renal Transplant Unit, Instituto de Nefrologia Nephrology, Buenos Aires, Argentina.

    HCV infection is associated to chronic hepatitis, cirrhosis, hepatic carcinoma and increased incidence of diabetes. Combination of new antiviral drugs have demonstrated utility in liver…
  • 2018 American Transplant Congress

    Diagnostic Performance of Blood Pressure Measurement Modality in Prospective Living Kidney Donors

    S. Armanyous, M. Lioudis, G. Thomas, E. Poggio, J. Augustine.

    Nephrology, Cleveland Clinic, Cleveland, OH.

    Background: Precise blood pressure (BP) measurement to exclude hypertension (HTN) is critical in evaluating living kidney donors (LKDs). 24-hour ambulatory blood pressure monitoring (ABPM) is…
  • 2018 American Transplant Congress

    The Technique of Ileobladder and Kidney Transplantation in Rats and Pigs

    M. Haberal,1 M. Kirnap,1 D. Ersoz,1 D. Bacanli,2 Z. Ersoy,3 M. Bayzakov,1 A. Torgay,3 H. Ozdemir.4

    1Transplantation, Baskent University, Ankara, Turkey; 2Research Center, Baskent University, Ankara, Turkey; 3Anesthesiology, Baskent University, Ankara, Turkey; 4Pathology, Baskent University, Ankara, Turkey.

    Introduction: Small, poor compliant or unstable bladders are a major problem in patients waiting for renal transplantation (RT). The experimental technique aims to develop and…
  • 2018 American Transplant Congress

    Allogeneic Mesenchymal Stem Cells as Induction Therapy Are Safe and Feasible in Renal Allografts: Pilot Results of a Multicenter Randomized Controlled Trial

    Q. Sun,1 F. Han,1 M. Zhao,2 R. Cao,3 D. Zhao,1 Z. Huang,1 L. Hong,1 Y. Peng,1 Q. Sun.1

    1Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; 2Zhujiang Hospital, Southern Medical University, Guangzhou, China; 3Second Affiliated Hospital, Guangzhou Traditional Chinese Medicine University, Guangzhou, China.

    Background: Delayed graft function (DGF) and acute rejection lead to adverse effects on graft outcomes. Optimal induction intervention should include both renal structure injury repair…
  • 2018 American Transplant Congress

    Predicting Survival after Deceased-Donor Kidney Transplants by Donor-Recipient Match: Who Can Tolerate a High-KDPI Kidney?

    S. Bae, J. Garonzik Wang, K. Jackson, A. Thomas, X. Luo, A. Massie, D. Segev.

    Johns Hopkins School of Medicine, Baltimore, MD.

    Deceased-donor kidney transplantation (DDKT) with high-KDPI kidneys carries an additional risk of mortality and graft failure, which could be tolerable for some candidates but detrimental…
  • 2018 American Transplant Congress

    The Impact of Rituximab Dose on Hepatitis B Virus Reactivation in HBsAg-Negative/anti-HBc-Positive Kidney Transplant Recipients

    J. Lee,1 J. Park,2 Y. Jung,1 D. Kim,1 J. Lee,1 S. Song,3 J. Lee,4 J. Lee,1 B. Kim,5 M. Kim,1 S. Kim,1 Y. Kim,1 K. Huh.1

    1Surgery, Yonsei University College of Medicine, Seoul, Korea; 2Internal Medicine (Gastroenterology), Yonsei University College of Medicine, Seoul, Korea; 3Surgery, Ewha Womans University, School of Medicine, Seoul, Korea; 4Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Korea; 5Internal Medicine (Nephrology), Yonsei University College of Medicine, Seoul, Korea.

    Background: Hepatitis B virus (HBV) reactivation is well-recognized complication of rituximab. Although use of rituximab for sensitized patients continues to increase in kidney transplantation, the…
  • « Previous Page
  • 1
  • …
  • 289
  • 290
  • 291
  • 292
  • 293
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences